| ADVANCED IN VITRO CELL TECHNOLOGIES, S.L. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120034642 | METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF REPRODUCING IN VITRO THE METABOLIC IDIOSYNCRASY OF HUMANS - The method is based on the use of expression vectors coding for the sense and anti-sense mRNA of the Phase I and Phase II drug biotransformation enzymes showing a greatest variability in humans for transforming cells expressing reductase activity. Such vectors can modulate (increase or decrease) the individualized expression of an enzyme without affecting the other enzymes. This singular cell model can reproduce in vitro the metabolic idiosyncrasy of humans. It is applicable in the study of development of new drugs, specifically in the study of metabolism, potential idiosyncratic hepatotoxicity, medicament interactions, etc., of new drugs. | 02-09-2012 |
| 20100038369 | BOX FOR TRANSPORTING SAMPLES - The present invention relates to a box for transporting samples, conceived to maintain the temperature in its interior in a range between 15° C. and 25° C. for an extended time period and suitable for any product that requires thermal and mechanical resistance, particularly for biological samples. The transport box of the invention comprises a series of non-primary packaging of carefully selected dimensions, shape and materials, accumulating heat elements and, optionally, filling material. | 02-18-2010 |
| 20080317864 | Chitosan and Heparin Nanoparticles - The invention is aimed at nanoparticulate systems for the controlled release of heparin. It is specifically aimed at nanoparticulate systems comprising chitosan, heparin and optionally a polyoxyethylenated derivative, and which are ionically cross-linked, as well as being aimed at processes for obtaining them. | 12-25-2008 |
